Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Boston Scientific (BSX), which belongs to ...

Boston Scientific’s BSX robust expansion of operations across different geographies outside the United States is poised to help it grow in the upcoming quarters. The company’s Electrophysiology (EP) ...

Needham has recently reduced Boston Scientific Corp (BSX) stock to Hold rating, as announced on October 18, 2024, according to Finviz. Earlier, on May 30, 2024, Goldman had initiated the stock to Buy, ...

The recall involves updating instructions for use rather than removing the device, POLARx Cryoablation Balloon Catheters, ...

Boston Scientific closes the year at historic highs, with investors refusing to liquidate even at these levels. Check out why ...

This was the stock's third consecutive day of losses.

Devices already in inventory can be used with the updated instructions by doctors. Patients already treated don’t need to do ...

In a report released today, Marie Thibault from BTIG maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Boston Scientific (BSX) reachead $89.86 at the closing of the latest trading day, reflecting a +1.02% change compared to its last close.

Boston Scientific (BSX – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Patrick ...

The stock's fall snapped a five-day winning streak.